Effects of high dose octreotide on retrograde bile salt-induced pancreatitis in rats

Peptides

Volumn 19, Issue 3, 1998, Pages 543-547

  Chen, Chun Chia ^a,b   Wang, Sun Sang ^a   Tsay, Shyh Haw ^b   Lee, Fa Yauh ^a   Wu, Shwn Ling ^a   Lu, Rei Hwa ^a   Chang, Full Young ^a   Lee, Shou Dong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Acute pancreatitis; Octreotide; Rat; Taurodeoxycholate

Indexed keywords

AMYLASE; BILE SALT; OCTREOTIDE; SOMATOSTATIN; TAURODEOXYCHOLIC ACID; TRIACYLGLYCEROL LIPASE;

ACUTE HEMORRHAGIC PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; EDEMA; HISTOPATHOLOGY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; NONHUMAN; PANCREAS HEMORRHAGE; PANCREAS NECROSIS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

AMYLASES; ANIMALS; BILE ACIDS AND SALTS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HEMATOCRIT; LIPASE; MALE; OCTREOTIDE; PANCREATITIS, ACUTE NECROTIZING; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL ANALYSIS; TAURODEOXYCHOLIC ACID;

EID: 0031954664     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00453-1     Document Type: Article

References (28)

1. Aho H. J., Koskensalo S. M. L., Nevalainen T. J. Experimental pancreatitis in the rat sodium taurocholate induced acute haemorrhagic pancreatitis . Scand. J. Gastroenterol. 15:1980;411-416.
2. Ais G., Novo C., Ortega M., Gonzalez A., Jimenez I., Lopez J., Romeo J. M. Effect of somatostatin on the hemodynamic changes induced by acute experimental pancreatitis in the conscious rat. Revista Espanola de Enfermedades Digestivas. 85:1994;193-198.
3. Arcidiacono R., Gambitta P., Rossi A., Grosso C., Bini M., Zanasi G. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Endoscopy. 26:1994;715-718.
4. Banks P. A. Acute pancreatitis medical and surgical management . Am. J. Gastroenterol. 89:(Suppl):1994;78-85.
5. Bauer W., Briner U., Doepfner W., Haller R., Huguenin R., Marbach P., Petcher T. J., Pless J. SMS 201-995 a very potent and selective octapeptide analogue of somatostatin with prolonged action . Life Sci. 31:1982;1133-1140.
6. Baxter J. N., Jenkins S. A., Day D. W., Roberts N. B., Cowell D. C., Mackie C. R., Shields R. Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat. Br. J. Surg. 72:1985;382-385.
7. Becker V. Pathological anatomy and pathogenesis of acute pancreatitis. World J. Surg. 5:1981;303-313.
8. Binder M., Uhl W., Friess H., Malfertheiner P., Büchler M. W. Octreotide in the treatment of acute pancreatitis result of a unicenter prospective trial with three difference octreotide dosages . Digestion. 55:(Suppl 1):1994;20-23.
9. Carballo F., Domingues E., Fernandez-Calvet L., Martinez-Pancorbo C., Garcia A., De la Morena J. Is somatostatin useful in the treatment of acute pancreatitis? A meta-analysis . Digestion. 49:1991;12-13.
10. Carlsson P., Jansson L. The long-acting somatostatin analogue octreotide decreases pancreatic islet blood flow in rats. Pancreas. 9:1994;361-364.
11. Chen C. C., Wang S. S., Chao Y., Lu C. W., Lee S. D., Tsai Y. T., Lo K. J. C reactive protein and lactate dehydrogenase isoenzymes in the assessment of the prognosis of acute pancreatitis. J. Gastroenterol. Hepatol. 7:1992;763-766.
12. Chen C. C., Wang S. S., Tsay S. H., Lee F. Y., Wu S. L., Lu R. H., Lee S. D. A model of experimental acute necrotizing pancreatitis. Chin. Med. J. (Taipei). 56:1995;373-379.
13. Conway D. R., Djuricin G., Prinz R. A. The effect of somatostatin analogue (SMS 201-995) on pancreatic blood flow. Surgery. 104:1988;1024-1030.
14. Degertekin H., Ertan A., Akdamar K., Yates R., Chen I., Coy D. H., Arimura A. Effects of somatostatin and a somatostatin agonist on diet-induced pancreatitis in mice. Peptides. 6:1985;1245-1247.
15. Del Pozo E., Neufeld K., Schlüter F., Clarenbach P., Bieder E., Wendel L., Nüesch E., Marbach P., Cramer H., Kerp L. Endocrine profile of a long-acting somatostatin derivative SMS 201-995 Study in normal volunteers following subcutaneous administration . Acta Endocrinol. 111:1986;433-439.
16. Jenkins S. A., Baxter J. N., Day D. W., Al-Sumidaie A. M., Leinster S. J., Shields R. The effect of somatostatin and SMS 201-995 on experimentally-induced pancreatitis and endotoxemia in rats and on monocyte activity in patients with cirrhosis and portal hypertension. Klin. Wochenschr. 64:1986;100-106.
17. Jenkins S. A., Ellenbogen S., Day D. W., Roberts N., Baxter J. N. Effects of SMS 201-995 on reticuloendothelial system (RES) activity in rats with acute pancreatitis. Gut. 28:1987;A1381.
18. Lankisch P. G., Koop H., Winckler K., Fölsch U. R., Creutzfeldt W. Somatostatin therapy of acute experimental pancreatitis. Gut. 18:1977;713-716.
19. Li Y., Owyang C. Somatostatin inhibits pancreatic enzyme secretion at a central vagal site. Am. J. Physiol. 265:1993;G251-G257.
20. Mckay C. J., Imrie C. W., Baxter J. N. Somatostatin and somatostatin analogues - are they indicated in the management of acute pancreatitis? Gut. 34:1993;1622-1626.
21. Niederau C., Niederau M., Lüthen R., Strohmeyer G., Ferrell L. D., Grendell J. H. Pancreatic exocrine secretion in acute experimental pancreatitis. Gastroenterology. 99:1990;1120-1127.
22. Ooijen B. V., Tinga C. J., Kort W. J., Zijlstra F. J., Lamberts W. J., Paul Wilson J. H. Effects of long-acting somatostatin analog (SMS 201-995) on eicosanoid synthesis and survival in rats with acute necrotizing pancreatitis. Dig. Dis. Sci. 37:1992;1434-1440.
23. Schlarman D. E., Beinfeld M. C., Andrus C., Kaminski D. L. Effects of somatostatin on acute canine experimental pancreatitis. Int. J. Pancreatol. 2:1987;247-255.
24. Schmidt J., Rattner D. W., Lewandrowski K., Compton C. C., Mandavilli U., Knoefel W. T., Warshaw A. L. A better model of acute pancreatitis for evaluating therapy. Ann. Surg. 215:1992;44-56.
25. Steer M. L., Meldolesi J. Pathogenesis of acute pancreatitis. Annu. Rev. Med. 39:1988;95-105.
26. Sternlieb J. M., Aronchick C. A., Retig J. N., Dabezies M., Saunders F., Goosenberg E., Infantolino A., Inonna S., Maislin G., Wright S. H. A multicenter randomized controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. Am. J. Gastroenterol. 87:1992;1561-1566.
27. Usadel K. H., Kessler H., Rohr G., Kusterer K., Palitzsch K. D., Schwedes U. Cytoprotective properties of somatostatins. Klin. Wochenschr. 64:(suppl 7):1986;59-63.
28. Zhu Z. H., Holt S., El-Lbishi M. S., Grady T., Taylor T. V., Powers R. E. A somatostatin analogue is protective against retrograde bile salt-induced pancreatitis in the rat. Pancreas. 6:1991;609-613.